
Weak Shield: Mild COVID‑19’s Antibodies Fade Quickly, 100 Million Endure Long COVID
Antibody protection after mild Covid-19 may not last; an estimated 100m people have had long Covid, World News,The following is a summary of some recent studies on Covid-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.